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Edited by Jesus AvilaAbstract Fluorescent proteins are versatile tools for live cell
imaging studies. In particular, recent progress was achieved in
the development of monomeric red ﬂuorescent proteins (mRFPs)
that show improved properties in respect to maturation and
intracellular ﬂuorescence. mRFPmars, a red ﬂuorescent protein
designed especially for the use in Dictyostelium, proved to be a
brilliant label for diﬀerent cytoskeletal elements. Here we report
on the synthesis of a humanized version of a monomeric RFP,
mRFPruby, which diﬀers in sequence from mRFPmars in four
amino acids and has a codon usage that is optimized for the
application in mammalian cells. In order to demonstrate the use-
fulness of this new mRFP variant, mRFPruby fused to b-actin
was expressed in diﬀerent mouse cell lines and used to visualize
actin cytoskeleton dynamics by live cell microscopy.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Synthetic gene1. Introduction
Genetically encoded ﬂuorescent proteins are now widely
used as markers that allow visualizing the distribution of indi-
vidual proteins or highlighting of cellular compartments [1,2].
In addition to visualize localization or to track redistribution,
aspects of protein dynamics and interaction of speciﬁc compo-
nents can be studied within living cells. Naturally occurring
ﬂuorescent proteins like the Aequorea victoria green ﬂuorescent
protein (GFP) [3] or variants of it as well as the advent of new
ﬂuorescent proteins [4,5] now oﬀer researchers a full palette of
ﬂuorescent markers suitable for live cell imaging studies.
Proteins emitting in the red or far-red range are particularly
useful, because they show reduced autoﬂuorescence in eukary-
otic cells. In addition, since the emission spectra of red ﬂuores-
cent proteins (RFPs) can be clearly separated from GFP, they
are also ideally suited for use in multicolor labeling. The ﬁrst
generation of RFPs was derived from the coral Discosoma.*Corresponding author. Fax: +49 89 28913363.
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doi:10.1016/j.febslet.2006.03.082These ﬂuorescent labels, denoted as DsRed [6–8], and variants
of it have the disadvantage of being obligate tetramers and are
characterized by slow maturation and relatively weak ﬂuores-
cence. However, consecutive runs of mutagenesis of DsRed
and selection of stronger ﬂuorescing variants led to the identi-
ﬁcation of RedStar, having seven altered amino acids [9]. By
sequential mutagenesis of DsRed, a monomeric RFP, mRFP1,
was obtained [10]. Another new version of mRFPs, mRFP-
mars [11], was originally designed for the use in Dictyostelium
live cell imaging studies. For this purpose, a synthetic gene was
produced that encoded a derivative of DsRed that combined
the mutations that made the protein brighter [9], and mono-
meric [10], and employed the highly A/T-rich codon usage
found in the genome of Dictyostelium [12]. mRFPmars turned
out to be a brilliant ﬂuorescence tag for various proteins in
Dictyostelium [11,13], however, it was not suitable for expres-
sion in combination with other proteins in diﬀerent mamma-
lian cell lines (unpublished observations).
To overcome this insuﬃciency, we synthesized a RFP-gene
encoding a protein with the amino acid sequence of Dictyoste-
lium mRFPmars, but based on the codon usage found in hu-
mans. During the screen for correct clones in bacteria,
several mutations of the original sequence of mRFPmars were
obtained in addition to the humanized mRFPmars sequence.
One of these clones, mRFPruby, had four additional amino
acid changes when compared to the original mRFPmars amino
acid sequence. We have tested the humanized variant mRFP-
ruby in combination with b-actin in diﬀerent mouse cell lines.
mRFPruby-b-actin turned out to be a suitable label to visual-
ize the diﬀerent actin structures observed in mammalian cells.2. Materials and methods
2.1. Materials, bacterial strains and plasmids
Restriction enzymes and T4 DNA ligase were from New England
Biolabs. EXT DNA Polymerase and Taq polymerase were from Finn-
zymes (Epsoo, Finland). Oligonucleotides were synthesized by Thermo
Electron GmbH (Ulm, Germany). DNA fragments were puriﬁed with
the CP-Kit, Gel Extraction Kit or Miniprep Kits from Peqlab (Erlan-
gen, Germany) or Qiagen (Hilden, Germany). Polyclonal anti-actin
antibody was purchased from Sigma (A 2066).
Unless otherwise stated, bacteria were grown at 37 C in LB medium
containing 170 mg ampicillin per l.
2.2. Sequence adaptation
The amino acid sequence corresponding to mRFPmars [11] was
optimized using the program package DNAWorks (http://
mcl1.ncifcrf.gov/dnaworks/dnaworks2.html), which reverse-translated
the protein sequence using the codon frequency table for Homo sapiensblished by Elsevier B.V. All rights reserved.
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sequence. The algorithm of the program was used to divide the
optimized gene sequence into 36 sections, which were characterized
by an average annealing temperature of 58 C and a maximum
length of 50 bases (Table 1). The codon frequency threshold was set
to 50%.2.3. Gene assembly, ampliﬁcation, and cloning
Oligonucleotides were obtained on a 20-nmol scale with standard
RP-HPLC puriﬁcation. Stock solutions were prepared at a concentra-
tion of 100 lM in water. Equal volumes of stock solutions were mixed
together and diluted to a concentration of 2.5 lM. 1 ll of the mixed
primers was employed in a PCR. The ﬁnal concentrations of compo-
nents were 25 nM of each oligonucleotide, 750 mM Tris/HCl, pH
9.0, 200 mM (NH4)2SO4, 0.1% (w/v) Tween 20, 15 mM MgCl2,
0.2 mM for each dNTP and 1 U of EXT Polymerase. The PCR proto-
col for gene assembly started with a 5-min denaturation step at 95 C,
followed by 25 cycles of denaturation at 95 C for 30 s, annealing at
58 C for 30 s and extension at 72 C for 1 min. The last step was an
incubation cycle at 72 C for 2 min. 1 ll of this PCR product served
as template, and the two ﬂanking oligonucleotides HSRFP-1FW and
HSRFP-1RV were used as primers in a subsequent 25-cycle ampliﬁca-
tion reaction (Fig. 1A).
The resulting 750-bp DNA-fragment was digested with EcoRI and
BglII, subsequently cloned into the expression plasmid pNCO113
[15] (EcoRI/BamHI), and transformed into Escherichia coli strain
XL-1 Blue [16] resulting in the recombinant strain XL-1-pNCO-
HSmRFPmars. After the selection of brilliant red colored colonies,
plasmids were puriﬁed and sequenced (GATC Biotech, Konstanz,
Germany).Table 1
Oligonucleotides used for the construction of the synthetic gene encoding hu
Designation Sequence (50 to 3 0)
HSRFP-1FW ataatagaattcattaaagaggaga
HSRFP-2FW gcttaccatggccagctccgaggat
HSRFP-3FW gatttaaggtcaagatggagggaag
HSRFP-4FW gttcgagattgagggagaaggagaa
HSRFP-5FW gagggcacacaaaccgctaagctca
HSRFP-6FW ggacccctccccttcgcctgggata
HSRFP-7FW ctcagttccagtacggaagcaaagc
HSRFP-8FW gccgacatccctgactatctgaagc
HSRFP-9FW ggcttcaagtgggagagaatcatga
HSRFP-10FW ggcgtggtgacagtcacacaagata
HSRFP-11FW gacggagagtttatttataaggtga
HSRFP-12FW tccgatggccctgtcatgcaaaaaa
HSRFP-13FW gaagcctccaccgagagaatgtatc
HSRFP-14FW ctctgaaaggcgaaattaaaatgag
HSRFP-15FW cactacgatgccgaggtcaaaacaa
HSRFP-16FW aacaagtgcagctgcctggcgccta
HSRFP-17FW ctcgacattatcagccataatgagg
HSRFP-18FW gagagagctgagggcagacatagca
HSRFP-1RV tattattatagatcttattatggat
HSRFP-2RV tctgccctcagctctctcatattgt
HSRFP-3RV ctcattatggctgataatgtcgagt
HSRFP-4RV aggcagctgcacttgtttcttggcc
HSRFP-5RV gacctcggcatcgtagtgtcctccg
HSRFP-6RV tctcattttaatttcgcctttcaga
HSRFP-7RV ctctcggtggaggcttcccatccca
HSRFP-8RV tgacagggccatcggaggggaagtt
HSRFP-9RV agtttcaccttataaataaactctc
HSRFP-10RV tgactgtcaccacgcctccgtcctc
HSRFP-11RV attctctcccacttgaagccttcag
HSRFP-12RV gatagtcagggatgtcggcagggtg
HSRFP-13RV gcttccgtactggaactgagggctc
HSRFP-14RV gaaggggaggggtcctccttttgtg
HSRFP-15RV cggtttgtgtgccctcgtaaggccg
HSRFP-16RV ccttctccctcaatctcgaactcgt
HSRFP-17RV ttccctccatcttgaccttaaatct
HSRFP-18RV gagctggccattgtgagtttgccca2.4. Expression and puriﬁcation of humanized mRFPmars and
mRFPruby
Plasmids isolated from the strain XL-1-pNCO-HSmRFPmars-7
(further designated as mRFPruby) and XL-1-pNCO-HSmRFP-8 (fur-
ther designated as humanized mRFPmars) were transformed in E. coli
M15 [pREP4] cells [17] and cultivated under shaking conditions at
37 C in LB medium containing 170 mg ampicillin an 20 mg kanamy-
cine per l up to an optical density of 0.6 at 600 nm. Isopropyl-b-D-thi-
ogalactoside (IPTG) was added to a ﬁnal concentration of 2 mM, and
incubation was continued overnight. The bacteria were harvested by
centrifugation, washed with 0.9% NaCl and stored at 20 C.
Bacterial pellets were suspended in 50 mM Tris/HCl, pH 8.5 (buﬀer
A), cooled on ice and ultrasonicated. After centrifugation (13000 rpm,
15 min, 4 C), ammonium sulfate was added to the supernatant to a ﬁ-
nal concentration of 1.0 M. The solution was placed on top of a Phe-
nyl-Sepharose column (1.6 · 10 cm, Amersham Pharmacia Biotech,
Freiburg, Germany), equilibrated with buﬀer A containing 1.0 M
ammonium sulfate. The column was developed with a linear gradient
of 1.0–0 M ammonium sulfate in buﬀer A. Fractions were analyzed
by SDS gel electrophoresis. Fractions containing humanized mRFP-
mars or mRFPruby, respectively, were combined and concentrated
by ultraﬁltration. The protein solution was desalted using a HiPrep
desalting column (2.6 · 10 cm, Amersham Pharmacia Biotech), and
placed on top of a Source-15Q column (1.0 · 10 cm, Amersham Phar-
macia Biotech), which was equilibrated with buﬀer A. The column was
developed with a linear gradient of 0–1.0 M KCl in buﬀer A. Fractions
were combined, concentrated by ultraﬁltration, and the protein solu-
tion was loaded on top of a Superdex 75 column (2.6 · 60 cm, Amer-
sham Pharmacia Biotech) and eluted with 50 mM Tris/HCl, pH 7.5,
containing 100 mM potassium chloride. mRFP containing red-colored
fractions were combined and concentrated.manized mRFPmars
Length
aattaactatgggcaa 41
gtcatcaaagagtttatga 44
cgtcaacggacacga 40
ggccggccttac 37
aggtcacaaaagga 39
ttctgagcc 34
ctatgtgaaacaccct 41
tctccttccctgaa 39
acttcgaggacgga 39
gcaccctccaa 36
aactcagaggaaccaacttcccc 48
aaacaatgggatgg 39
ctgaggatggcg 37
actgaaactcaaagacggagga 47
cctacaaggccaaga 40
caagacagatattaaa 41
actacaccatcgtggaacaatat 48
caggcgctggatcc 34
ccagcgcctgtgctatg 42
tccacgatggtgtagtc 42
ttaatatctgtcttgtaggcgcc 48
ttgtaggttgtttt 39
tctttgagtttcag 39
gcgccatcctcaggatacatt 46
ttgtttttttttgca 40
ggttcctctg 35
cgtcttggagggtgctatcttgtg 49
gaagttcatg 35
ggaaggagagcttca 40
tttcacataggcttt 40
agaatatcccaggc 39
accttgagcttag 38
gccttct 32
gtccgttgacgc 37
cataaactctttgatgacatcctcg 50
tggtgagcttc 36
M. Fischer et al. / FEBS Letters 580 (2006) 2495–2502 24972.5. Characterization and analytical ultracentrifugation of puriﬁed
mRFPs
Absorption spectra were measured using a UV–VIS
spectrophotometer (Ultrospec 2000, Amersham Pharmacia Biotech),
and ﬂuorescence spectra with a FluoroMax-2 spectroﬂuorimeter
(Jobin Yvon Horiba, Munich, Germany) at room temperature in
10-mm quartz cuvettes. For quantum yield determination, the ﬂuores-
cence intensities of protein solutions of mRFPruby were compared
with ﬂuorescence intensities of solutions of mRFP1 and mRFPmars
(ﬂuorescence quantum yield: 0.25) [10,11] in 100 mM potassium phos-
phate, pH 7.0.
Analytical ultracentrifugation experiments were performed with an
analytical ultracentrifuge (Optima XL-A, Beckman Instruments, Palo
Alto, CA) equipped with absorbance optics. Aluminum double sectorFig. 1. Construction of a humanized mRFPmars. (A) Assembly of 36 oligo
mRFPmars. 5 0 and 3 0 overhangs including restriction sites for the cloning in
fusion proteins in eukaryotic vector systems (HindIII and BamHI, boxed) we
forward oligonucleotides; HSRFP-1RV to 18RV, reverse oligonucleotides. (B
the X-ray structure of DsRed adopted from Yarbrough et al. [22]. The DsRe
mRFPmars [11] are drawn in green; the four mutated residues leading to the
red. Three of four residues mutated in mRFPruby are located on the surfac
structure. Below: Sequence comparison of mRFPruby (this study), mRFPmcells equipped with quartz windows were used throughout. The partial
speciﬁc volume was estimated from the amino acid composition yield-
ing a value of 0.7319 ml g1 for mRFPruby [18].
Sedimentation equilibrium experiments were performed with 50 mM
Tris–hydrochloride, pH 7.5, containing 100 mM potassium chloride
and 0.4 mg of protein per ml at 17500 rpm and 4 C.
2.6. Cloning of mRFPruby-b-actin
A modiﬁed pcDNA3 expression vector (Invitrogen, Karlsruhe,
Germany) containing GFP-human-b-actin under control of an human
b-actin promoter (PAGA) was a gift of Bernhard Wehrle-Haller
(Geneva, Switzerland), and was used to construct a corresponding
mRFP vector. The GFP-encoding sequence was replaced by both
humanized mRFP sequences (mRFPmars and mRFPruby).nucleotides for the construction of a synthetic humanized version of
to pNCO113 (EcoRI and BglII, underlined), and for the generation of
re added to the coding region of mRFPmars. HSRFP-1FW to 18FW,
) Top: Positions of the converted amino-acid residues superimposed on
d chromophore is drawn in yellow, the six mutated residues leading to
enhanced version of mRFPmars, designated mRFPruby, are drawn in
e of the protein. The amino acid exchange A57S is located within the
ars [11], mRFP1 [10] and DsRed [8].
Fig. 1 (continued )
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NIH 3T3 mouse ﬁbroblasts were obtained from the American Type
culture collection. Immortalized mouse chondrocytes were a kind gift
from Professor Reinhard Fa¨ssler (Martinsried, Germany). All cell lines
were maintained in DMEM supplemented with 10% fetal calf serum
(Invitrogen, Karlsruhe, Germany). Cells were transiently transfected
using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
protocol at a DNA:reagent ratio of 1:2.5 and assessed for expression of
ﬂuorescent proteins by video microscopy and/or FACS analysis 24–
32 h after transfection.
2.8. FACS analysis of transfected cell cultures
For ﬂow cytometry, transfected cells were trypsinized and washed
twice in PBS containing 1% bovine serum albumin. FACS analysis
was performed on a FACSCalibur system (Becton Dickinson, Frank-
lin Lakes, NJ) using CellQuest Pro software (Becton Dickinson).
2.9. Microscopy
For video microscopic observations, transfected cells were seeded
onto glass bottom culture dishes (MatTek, Ashland, MA) pre-coated
with 10 lg/ml bovine plasma ﬁbronectin (Calbiochem, San Diego,CA) in PBS. Live cells were recorded using a Zeiss Axiovert 300M in-
verted microscope equipped with a CCD camera (Roper Scientiﬁc, Du-
luth, GA) and a stage incubator (EMBL Precision Engineering,
Heidelberg, Germany). MetaMorph software (Molecular Devices,
Downingtown, PA) was used for microscope control and image
acquisition.3. Results
3.1. Synthesis of humanized versions of mRFP
The gene coding for a humanized version of mRFPmars [11]
was synthesized by oligonucleotide assembly and subsequent
PCR ampliﬁcation (Fig. 1A). Thirty-six oligonucleotides were
employed to assemble the synthetic mRFPmars gene that was
optimized for expression in human cells by replacement of 153
codons and thereby triggering the GC-content to 50.2%. The
synthetic DNA fragment was cloned into the bacterial expres-
sion vector pNCO113 [15].
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and brilliance, and the coding sequences were monitored by
DNA sequencing. During the process of screening, one mu-
tant, HS-mRFPmars-7, further designated as mRFPruby,
was found to be more brilliant and to mature faster in
E. coli cells than the original mRFPmars clone. Gene analysis
of the mRFPruby variant indicated that the mutated protein
has four additional exchanges, A57S, I96F, K194M, and
E206G, as compared to the mRFPmars amino acid sequence.
Three of the four mutations are located on the surface of the
protein, A57S lies within the structure (Fig. 1B).
The recombinant E. coli strains carrying the synthetic gene
variants under the control of a T5 promoter and lac operator
produced a 27.5 kDa protein that constituted approximately
10% of the total protein mass when using the conditions for
expression described in Section 2. Both humanized mRFP
variants, mRFPmars and mRFPruby, were puriﬁed by hydro-
phobic interaction chromatography followed by anion ex-
change and gel ﬁltration chromatography. The puriﬁed
proteins appeared homogeneous (MW 27.5 kDa) as judged
by sodium dodecyl polyacrylamide gel electrophoresis, in
agreement with sedimentation equilibrium experiments indi-
cating a molecular mass of 27 kDa using an ideal monodis-
perse model for calculation (Fig. 2). Compared with the
calculated molecular mass of 27.5 kDa, the experimental data
are in agreement with mRFPruby having a monomeric quater-
nary structure.
The absorbance and emission spectra of humanized mRFP-
mars and mRFPruby showed no signiﬁcant diﬀerences (Fig. 3),
and are almost identical to the previously published absor-
bance spectra of mRFP1 [10] and Dictyostelium mRFPmars
[11]. The extinction coeﬃcient (e) for mRFPruby at 585 nmFig. 2. Sedimentation equilibrium centrifugation of mRFPruby.
Protein concentration was monitored photometrically at 280 nm.
The partial speciﬁc volume was estimated from the amino acid
composition yielding a value of 0.7319 ml g1 for mRFPruby. Exper-
iments were performed with 50 mM Tris–hydrochloride, pH 7.5,
containing 100 mM potassium chloride and 0.4 mg of protein per ml at
17500 rpm and 4 C. Residuals are shown at the top.was 32297 M1 cm1. An pH dependency of the shorter wave-
length absorption peak at 503 nm and the corresponding emis-
sion peak at 515 nm as described previously for the spectra of
Dictyostelium mRFPmars [11] and mRFP1 [10], was detected
also for both the spectra of humanized mRFPmars and
mRFPruby (data not shown). The determined ﬂuorescence
quantum yield for mRFPruby (0.25) was identical to that of
mRFP1 and mRFPmars.
3.2. mRFPruby used as ﬂuorescent tag in mouse cells
mRFPruby-labeled b-actin was expressed transiently in dif-
ferent mouse cell lines. Transfected mouse 3T3 ﬁbroblasts
expressing high levels of mRFPruby-b-actin could be detected
by ﬂuorescence activated cell sorting (FACS) analysis using a
488-nm excitation laser line, and were sorted demonstrating
the usefulness of mRFPruby for ﬂow cytometry applications
using standard instrumentation (Fig. 4A). In addition, the
expression of the mRFPruby-tagged actin was conﬁrmed by
Western blotting (Fig. 4B).
The detailed examination of mRFPruby-b-actin transfected
cells by ﬂuorescence microscopy revealed that the cytoskeletal
actin structures visualized are comparable to the ones observed
when using a well established GFP-b-actin construct [19].
Bright ﬂuorescence from mRFPruby was evident in F-actin-
rich structures such as stress ﬁbers and lamellipodia as well
as dot-like structures (Fig. 5), and ﬂuorescently tagged actin
in these structures showed similar dynamics in live-cell time
lapse recordings as established by previous live-cell imaging
studies using GFP-b-actin in these cells (Movie 1 in Supple-
mentary Material). Additionally, enrichment of mRFPruby-
labeled b-actin was prominent in the perinuclear space where
cellular G-actin is abundant. Abnormal, aggregated actin, a
common artifact with previous DsRed-based ﬂuorescence tags,
were observed only in cells expressing very high levels of
mRFPruby-b-actin.3.3. Double labeling studies using mRFPruby and green
ﬂuorescent markers
To further assess the correct localization of mRFPruby-
b-actin and its suitability for double labeling studies, we
performed two sets of experiments. First, a mouse cell line
(proﬁlin ﬂ/ﬂ immortalized chondrocytes) stably transduced
with GFP-b-actin was transfected with mRFPruby-b-actin.
Both signals showed an almost perfect colocalization
(Fig. 6A–C), conﬁrming that mRFPruby-b-actin localizes as
well as GFP-b-actin. From this result, we also conclude that
neither of the ﬂuorescence tagged actin forms is preferentially
incorporated into any actin structure.
Second, we co-transfected NIH 3T3 ﬁbroblasts with both
mRFPruby-b-actin and a well-established GFP-tensin con-
struct [20]. Tensin is an F-actin binding protein that localizes
to ﬁbrillar adhesions which are adhesion complexes formed
by cells adhering to ﬁbronectin. Fibrillar adhesions are an-
chored to actomyosin stress ﬁbers. We investigated cells
expressing a combination of mRFPruby-b-actin and GFP-
tensin to visualize simultaneously the entire actin cytoskeleton
and ﬁbrillar adhesions (Fig. 6D–F). Furthermore, we could
readily visualize the formation of ﬁbrillar adhesions partially
overlapping with actin bundles and record their dynamics in
time-lapse movies (not shown), conﬁrming the suitability of
mRFPruby for functional double labeling studies. These initial
Fig. 3. Spectral properties of equal concentrations of mRFPruby (solid line) and humanized mRFPmars (dotted line) in 100 mM potassium
phosphate, pH 7.0. (A) Absorption spectra. (B) Emission spectra. The excitation wavelength was 480 nm.
Fig. 4. Expression of mRFPruby-tagged b-actin in mammalian cells. (A) FACS proﬁles show ﬂuorescence emission at 515–545 nm of untransfected
control and mRFPruby-b-actin-transfected 3T3 ﬁbroblasts excited with a 488 nm laser line. Transfected cells are clearly detected as abroad peak
shoulder. (B) Western blot of untransfected control and mRFPruby-b-actin-transfected 3T3 ﬁbroblasts lysates probed with an anti-actin antibody.
Equal amounts of cell lysates were loaded per lane. Endogenous actin is detected as a prominent band at 42 kDa; below the 42 kDa band a
degradation product is sometimes observed. mRFPruby-b-actin is labeled as a less intense band of approximately 70 kDa.
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for dual-color labeling experiments aiming to elucidate dy-
namic processes like the ones involved in regulation of actin
polymerization.4. Discussion
In this study we report the development and testing of a
new humanized mRFP variant, mRFPruby, which was opti-
Fig. 5. Visualization of cytoskeletal structures using mRFPruby-b-actin. (A) Phase contrast and (B) ﬂuorescence image of NIH 3T3 ﬁbroblasts
transfected with mRFPruby-b-actin. Stress ﬁbers and lamellipodia are prominently labeled in the transfected cell. (C, D) Detailed views of 3T3
ﬁbroblasts transfected with mRFPruby-b-actin showing actin structures characteristic of lamellipodia. The leading edge, punctate focal complexes
and nascent stress ﬁbers can be distinguished. Bars: 10 lm.
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codon usage in the construct expressing the previously intro-
duced brilliant RFP, mRFPmars [11] – which was optimized
for Dictyostelium – hampered the expression of the gene in
mammalian cells. Vertebrates use codons that in most cases
are rarely used in prokaryotic or other eukaryotic organisms
and vice versa. Therefore, based on the preferred codon
usage of H. sapiens, we re-engineered the mRFPmars-encod-
ing gene without aﬀecting the encoded amino acid sequence
of the ﬂuorescent protein. The in vitro gene synthesis was
based on oligonucleotide assembly and subsequent PCR
ampliﬁcation. Insuﬃcient ﬁdelity of the DNA polymerase
and the oligonucleotides used for the construction of the syn-
thetic gene aﬀorded a library of mRFPmars mutant proteins
with diﬀerent properties in terms of maturation behaviour
and brilliance. One of these clones encoding mRFPruby
was found to be more brilliant and to mature faster in the
E. coli host as compared to the intended original variant,
mRFPmars. Sequence analysis of mRFPruby revealed four
amino acid changes not aﬀecting the quaternary structure
of the protein as proved by analytical ultracentrifugation.
Interestingly, these mutations mainly located on the surface
of the protein probably give rise to the enhanced ﬂuorescence
observed with this new mRFP variant upon expression
in vivo.Although various red ﬂuorescent proteins are now available
from diﬀerent sources [5], their suitability has often not been
assessed in live cell imaging studies. This is incongruous, since
the usefulness of a ﬂuorescent protein in imaging studies relies
on its activity and compatibleness in living cells. The function-
ality of a ﬂuorescent protein is determined by a number of
variables, some of which are diﬃcult to quantify, including
maturation time, photostability, toxicity, and brightness.
These parameters are of course important, but do not always
adequately describe how well a ﬂuorescent protein will be ex-
pressed or ﬂuorescence in a given cell. It has actually been
demonstrated that the relative brightness of diﬀerent DsRed
variants in a cellular environment does not necessarily follow
the order determined by in vitro spectroscopy [21]. Therefore,
it is also important to thoroughly test ﬂuorescent proteins
empirically in a variety of cellular systems and applications.
The palette of ﬂuorescent proteins now enables dual-color
labeling investigations with sharp discrimination of the emis-
sion wavelengths especially when combinations of green
(GFP) and red (RFP) ﬂuorescent proteins are employed. Our
results demonstrate that mRFPruby is a reliable ﬂuorophore
for live microscopy of mammalian cells. mRFPruby expressed
in combination with b-actin yielded bright, stable ﬂuorescence
combined with low cytotoxicity both alone or in combination
with GFP-tagged proteins and thus enabled the imaging of
Fig. 6. Dual color-imaging using mRFPruby-b-actin in combination with green ﬂuorophores. (A–C) Immortalized mouse chondrocytes stably
transduced with GFP-b-actin (B) were transfected with mRFPruby-b-actin (A). Both ﬂuorophores colocalize as seen in the merged image (C). (D–F)
3T3 ﬁbroblasts were co-transfected with mRFPruby-b-actin (D) and GFP-tensin (E). Note the typical elongated ﬁbrillar adhesions along stress ﬁbers.
The merged image is shown in (F) and colocalization is indicated by the yellow color. Bars: 10 lm.
2502 M. Fischer et al. / FEBS Letters 580 (2006) 2495–2502cytoskeletal structures. The ﬂuorescence of mRFPruby is
rather photo-stable and also oﬀers the possibility to record dy-
namic processes such as cytoskeletal dynamics over time. To
sum up, mRFPruby extends the repertoire of RFPs applicable
for imaging studies in mammalian cells and might prove useful
also in other combinations.
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